The Viscosity Reduction Platform offers proprietary excipient combinations to enable the subcutaneous formulation of highly concentrated protein biologics. It allows for efficient viscosity reduction while maintaining protein stability, leading to increased concentrations and improved downstream processing, supported by screening and feasibility testing services.
Features:- Excipient Combinations: The platform uses specialized excipient combinations designed to reduce the viscosity of protein formulations, enabling higher concentrations of biologics without compromising stability?
- Subcutaneous Delivery:
The platform facilitates subcutaneous administration of protein therapeutics, which is crucial for patient convenience and reduces the need for hospitalization. It helps address the challenges posed by the high viscosity of concentrated protein formulations
- Improved Syringability:
By reducing viscosity, the platform enhances the ease of delivery via syringes, making self-administration more feasible for patients
- ? Customizable Solutions:
The platform offers flexibility thanks to the different combinations that can be tested via the technical sample kits or feasibility service, allowing researchers to tailor the excipient combinations to their specific protein formulations